I am not able to read the article. "You have reach
Post# of 148274
Do you sense a little sarcasm here?
Quote:
CytoDyn has a single asset - leronlimab - which it is running through trials in nearly every major disease known to man.
The stock has seen huge movement after the company started with covid-19.
If the company manages to file its HIV BLA, the stock could shoot up.